HealthcareServices

Scleritis Market 2026–2030: Forecasting Business Opportunities Ahead

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the scleritis market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Scleritis Market from 2026 to 2030?

The scleritis market has demonstrated robust expansion in recent years. It is anticipated to grow from $3.93 billion in 2025 to $4.28 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.9%. The market’s historical growth can be attributed to the rising prevalence of autoimmune disorders, the utilization of corticosteroids in ocular therapy, the availability of immunosuppressive agents, an increasing number of ophthalmology clinics, and heightened awareness of ocular inflammatory diseases.

The scleritis market is anticipated to show significant expansion in the coming years, with projections indicating a rise to $5.95 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. This expected growth during the forecast period stems from factors such as the development pipeline of biologic drugs targeting ocular inflammation, the uptake of teleophthalmology platforms, the emergence of focused anti-inflammatory treatments, greater access to advanced imaging technologies, and the expansion of programs raising awareness for rare eye diseases. Dominant trends during this forecast timeframe include the broadened use of biologic therapies for ocular inflammation, an increasing reliance on corticosteroids and immunosuppressive agents, the growing preference for combination therapy methods, a heightened emphasis on early detection and diagnostic imaging, and the creation of innovative anti-inflammatory ophthalmic drugs.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21283&type=smp

What Drivers Are Affecting Demand In The Scleritis Market?

An increase in autoimmune diseases is projected to fuel the expansion of the scleritis market moving ahead. These conditions involve the body’s immune system erroneously targeting its own healthy cells and tissues, perceiving them as foreign threats. The surge in autoimmune diseases is associated with inherited susceptibilities, environmental influences, shifts in lifestyle, and enhanced awareness resulting in improved diagnosis. Scleritis is caused by autoimmune diseases due to an inflammatory immune response that incorrectly targets the scleral tissue, resulting in discomfort and erythema. As an illustration, in August 2024, Public Health Scotland, a national body in Scotland, disclosed data showing that the Scottish Multiple Sclerosis Register (SMSR) documented 455 newly identified MS patients in 2023. Consequently, the growing occurrence of autoimmune diseases is propelling the expansion of the scleritis market.

Which Segments Are Gaining Traction In The Scleritis Market?

The scleritis market covered in this report is segmented –

1) By Type: Anterior Scleritis, Posterior Scleritis, Other Types

2) By Treatment: Medication, Surgery, Other Treatment

3) By Distribution Channel: Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channel

4) By End-Users: Hospitals, Specialty Clinics, Home Healthcare, Other End-Users

Subsegments:

1) By Anterior Scleritis: Non-Necrotizing Anterior Scleritis, Necrotizing Anterior Scleritis

2) By Posterior Scleritis: Diffuse Posterior Scleritis, Nodular Posterior Scleritis, Scleritis With Choroidal Involvement

3) By Other Types: Chronic Scleritis, Recurrent Scleritis, Infectious Scleritis

Which Trends Are Shaping Activity Within The Scleritis Market?

Leading companies operating within the scleritis market are concentrating on the creation of advanced products, such as eye drops, aiming to alleviate underlying inflammation and provide practical, non-invasive treatment options for patients. Eye drops are liquid formulations intended for direct use in the eyes to manage various conditions including irritation, dryness, inflammation, or infections. For instance, in May 2023, Entod Pharmaceuticals, an India-based pharmaceutical company, launched CYCLOTEARS eye drops both in India and globally. This novel therapeutic solution for inflammatory eye disease incorporated proprietary SEDDS technology. The product enhances drug delivery and efficacy, presenting a pioneering method to address inflammation in DED. This innovation represents a significant advancement in eye inflammatory treatment, ocular myositis, and scleritis.

Who Are The Prominent Global Companies Shaping The Scleritis Market Landscape?

Major companies operating in the scleritis market are Pfizer Inc, Johnson And Johnson, F Hoffmann La Roche Ltd, Bayer AG, Novartis AG, Teva Pharmaceuticals USA Inc, Baxter International Inc, Boehringer Ingelheim, Regeneron Pharmaceuticals Inc, Fresenius Kabi USA LLC, Sun Pharmaceutical Industries Ltd, Perrigo Company, Horizon Therapeutics plc, Aurobindo Pharma Ltd, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals, Alvogen, Accord Healthcare, West Ward Pharmaceuticals, Jubilant Cadista Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Inc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/scleritis-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Scleritis Market?

North America was the largest region in the scleritis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the scleritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Scleritis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21283&type=smp

Browse Through More Reports Similar to the Global Scleritis Market 2026, By The Business Research Company

Bacterial Conjunctivitis Market Report 2026

https://www.thebusinessresearchcompany.com/report/bacterial-conjunctivitis-global-market-report

Dermatitis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Knee Bursitis Market Report 2026

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795